Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Pál S et al. | Technological and biopharmaceutical optimization of nystatin release from a multiparticulate based bioadhesive drug delivery system. | 2013 | Eur J Pharm Sci | pmid:23528741 |
Tevyashova AN et al. | Structure-antifungal activity relationships of polyene antibiotics of the amphotericin B group. | 2013 | Antimicrob. Agents Chemother. | pmid:23716057 |
Stoopler ET | Management of oral chronic graft-versus-host disease. | 2013 | J Can Dent Assoc | pmid:23763728 |
Heneedak HM et al. | HPLC and chemometric methods for the simultaneous determination of miconazole nitrate and nystatin. | 2012 Nov-Dec | J Chromatogr Sci | pmid:22879356 |
Alcântara CS et al. | Peel bond strength of resilient liner modified by the addition of antimicrobial agents to denture base acrylic resin. | 2012 Nov-Dec | J Appl Oral Sci | pmid:23329241 |
Houlton JJ et al. | Intranasal drug-induced fungal rhinopharyngitis. | 2012 Mar-Apr | Int Forum Allergy Rhinol | pmid:22253034 |
Usta Y | Persistent hiccups: an unusual presentation and treatment. | 2012 | J Pain Symptom Manage | pmid:22248794 |
Di Capua R et al. | Towards the realization of label-free biosensors through impedance spectroscopy integrated with IDES technology. | 2012 | Eur. Biophys. J. | pmid:22237602 |
Tester R et al. | The use of konjac glucomannan hydrolysates to recover healthy microbiota in infected vaginas treated with an antifungal agent. | 2012 | Benef Microbes | pmid:22348910 |
Bulacio L et al. | Oral infections caused by yeasts in patients with head and neck cancer undergoing radiotherapy. Identification of the yeasts and evaluation of their antifungal susceptibility. | 2012 | J Mycol Med | pmid:23518170 |